1. Build a Strong Employer BrandFirst up, let’s talk about your employer brand. Think of it as your company’s personality and reputation. In Japan’s competitive pharmaceutical and medical device industry, it’s crucial to stand out. You need to showcase your…
BUSINESS
Teva to Let Go of Japan Generic Business in 2025 but Denies Full Exit
Israel’s Teva Pharmaceutical Industries plans to divest its Japanese generic business in 2025, the company revealed on a recent earnings call. The divestment is likely the result of the intense competition the drug maker has faced in the Japan market.…
To read the full story
Related Article
BUSINESS
- Building New Plant in US Is Not a Solution to Potential Tariffs: Astellas CEO
February 25, 2025
- J&J to Terminate Business with Wholesaler Toho
February 25, 2025
- Antibiotic Fetroja Approved in South Korea: Shionogi
February 25, 2025
- Mitsubishi Tanabe’s Parkinson’s Drug Accepted for EMA Review
February 25, 2025
- Eisai Limits ALS Drug Shipment on Unexpectedly High Demand
February 21, 2025
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…